Jason Tardio - Net Worth and Insider Trading
Jason Tardio Net Worth
The estimated net worth of Jason Tardio is at least $0 dollars as of 2024-05-11. Jason Tardio is the COO of Ovid Therapeutics Inc and owns about 0 shares of Ovid Therapeutics Inc (OVID) stock worth over $0. Details can be seen in Jason Tardio's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jason Tardio has not made any transactions after 2022-09-12 and currently still holds the listed stock(s).
Transaction Summary of Jason Tardio
Jason Tardio Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jason Tardio owns 1 companies in total, including Ovid Therapeutics Inc (OVID) .
Click here to see the complete history of Jason Tardio’s form 4 insider trades.
Insider Ownership Summary of Jason Tardio
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OVID | Ovid Therapeutics Inc | 2022-09-12 | Chief Commercial Officer |
Jason Tardio Latest Holdings Summary
Jason Tardio currently owns a total of 1 stock. Jason Tardio owns 0 shares of Ovid Therapeutics Inc (OVID) as of September 12, 2022, with a value of $0.
Latest Holdings of Jason Tardio
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OVID | Ovid Therapeutics Inc | 2022-09-12 | 0 | 3.00 | 0 |
Holding Weightings of Jason Tardio
Jason Tardio Form 4 Trading Tracker
According to the SEC Form 4 filings, Jason Tardio has made a total of 1 transactions in Ovid Therapeutics Inc (OVID) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Ovid Therapeutics Inc is the sale of 17,344 shares on September 12, 2022, which brought Jason Tardio around $37,290.
Insider Trading History of Jason Tardio
- 1
Jason Tardio Trading Performance
Jason Tardio Ownership Network
Jason Tardio Owned Company Details
What does Ovid Therapeutics Inc do?
Who are the key executives at Ovid Therapeutics Inc?
Jason Tardio is the Chief Commercial Officer of Ovid Therapeutics Inc. Other key executives at Ovid Therapeutics Inc include director & 10 percent owner & CEO Jeremy M Levin , 10 percent owner Takeda Pharmaceuticals U.s.a., Inc. , and CMO and PMO Amit Rakhit .
Ovid Therapeutics Inc (OVID) Insider Trades Summary
Over the past 18 months, Jason Tardio made no insider transaction in Ovid Therapeutics Inc (OVID). Other recent insider transactions involving Ovid Therapeutics Inc (OVID) include a net purchase of 18,248 shares made by Jeremy M Levin ,
In summary, during the past 3 months, insiders sold 0 shares of Ovid Therapeutics Inc (OVID) in total and bought 18,248 shares, with a net purchase of 18,248 shares. During the past 18 months, 0 shares of Ovid Therapeutics Inc (OVID) were sold and 18,248 shares were bought by its insiders, resulting in a net purchase of 18,248 shares.
Ovid Therapeutics Inc (OVID)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ovid Therapeutics Inc Insider Transactions
Jason Tardio Mailing Address
Above is the net worth, insider trading, and ownership report for Jason Tardio. You might contact Jason Tardio via mailing address: 1460 Broadway, New York Ny 10036.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
